In asthma, miR-19a can promote the production of Th2 cytokine IL-13 by directly targeting PTEN, a signal transduction inhibitor suppressor of cytokine signaling 1 (SOCS1), and deubiquitinase A20 (73, 74). Here, IL13 is linked to asthma.